Pfizer en un dilema por el negocio de salud del consumidor

Pfizer is facing a decision on whether to sell, spin, or keep its Advil Chapstick unit, valued at $15 to $20 billion. The unit's future is uncertain due to changing consumer behaviors influenced by Amazon's entry into healthcare. GSK and Reckitt have pulled out as potential buyers, leaving the door open for companies like Colgate or P&G. The market dynamics are shifting, allowing potential buyers to offer less than Pfizer's desired price.

What is the estimated value of the consumer products unit discussed in the text?

How has Amazon's entry into healthcare affected traditional drugstore dynamics?

What factors are influencing Pfizer's decision-making regarding its consumer products business?

What potential buyers are mentioned as alternatives for Pfizer's consumer products?

What challenges do potential buyers face when considering the acquisition of Pfizer's unit?